The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Companion Animal Drugs-Global Market Insights and Sales Trends 2024
Synopsis
The global Companion Animal Drugs market size is expected to reach US$ 33550 million by 2029, growing at a CAGR of 2.8% from 2023 to 2029. The market is mainly driven by the significant applications of Companion Animal Drugs in various end use industries. The expanding demands from the Dogs, Cats, Horses and Others, are propelling Companion Animal Drugs market. Antibiotics and Antimicrobials, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Parasiticides segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 24%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Companion Animal Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Companion Animal Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Companion Animal Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Companion Animal Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Companion Animal Drugs covered in this report include Zoetis, Bayer, Boehringer Ingelheim, Eli Lilly, Merck, Vetoquinol, Virbac, Dechra Pharmaceuticals and Ceva Sante Animale, etc.
The global Companion Animal Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Zoetis
Bayer
Boehringer Ingelheim
Eli Lilly
Merck
Vetoquinol
Virbac
Dechra Pharmaceuticals
Ceva Sante Animale
Aratana Therapeutics
Global Companion Animal Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Companion Animal Drugs market, Segment by Type:
Antibiotics and Antimicrobials
Parasiticides
Others
Global Companion Animal Drugs market, by Application
Dogs
Cats
Horses
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Companion Animal Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Companion Animal Drugs market size is expected to reach US$ 33550 million by 2029, growing at a CAGR of 2.8% from 2023 to 2029. The market is mainly driven by the significant applications of Companion Animal Drugs in various end use industries. The expanding demands from the Dogs, Cats, Horses and Others, are propelling Companion Animal Drugs market. Antibiotics and Antimicrobials, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Parasiticides segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 24%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Companion Animal Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Companion Animal Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Companion Animal Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Companion Animal Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Companion Animal Drugs covered in this report include Zoetis, Bayer, Boehringer Ingelheim, Eli Lilly, Merck, Vetoquinol, Virbac, Dechra Pharmaceuticals and Ceva Sante Animale, etc.
The global Companion Animal Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Zoetis
Bayer
Boehringer Ingelheim
Eli Lilly
Merck
Vetoquinol
Virbac
Dechra Pharmaceuticals
Ceva Sante Animale
Aratana Therapeutics
Global Companion Animal Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Companion Animal Drugs market, Segment by Type:
Antibiotics and Antimicrobials
Parasiticides
Others
Global Companion Animal Drugs market, by Application
Dogs
Cats
Horses
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Companion Animal Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Companion Animal Drugs
1.1 Companion Animal Drugs Market Overview
1.1.1 Companion Animal Drugs Product Scope
1.1.2 Companion Animal Drugs Market Status and Outlook
1.2 Global Companion Animal Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Companion Animal Drugs Market Size by Region (2018-2029)
1.4 Global Companion Animal Drugs Historic Market Size by Region (2018-2023)
1.5 Global Companion Animal Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Companion Animal Drugs Market Size (2018-2029)
1.6.1 North America Companion Animal Drugs Market Size (2018-2029)
1.6.2 Europe Companion Animal Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Companion Animal Drugs Market Size (2018-2029)
1.6.4 Latin America Companion Animal Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Companion Animal Drugs Market Size (2018-2029)
2 Companion Animal Drugs Market by Type
2.1 Introduction
2.1.1 Antibiotics and Antimicrobials
2.1.2 Parasiticides
2.1.3 Others
2.2 Global Companion Animal Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Companion Animal Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Companion Animal Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Companion Animal Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Companion Animal Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Companion Animal Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Companion Animal Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Companion Animal Drugs Revenue Breakdown by Type (2018-2029)
3 Companion Animal Drugs Market Overview by Application
3.1 Introduction
3.1.1 Dogs
3.1.2 Cats
3.1.3 Horses
3.1.4 Others
3.2 Global Companion Animal Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Companion Animal Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Companion Animal Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Companion Animal Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Companion Animal Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Companion Animal Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Companion Animal Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Companion Animal Drugs Revenue Breakdown by Application (2018-2029)
4 Companion Animal Drugs Competition Analysis by Players
4.1 Global Companion Animal Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Companion Animal Drugs as of 2022)
4.3 Date of Key Players Enter into Companion Animal Drugs Market
4.4 Global Top Players Companion Animal Drugs Headquarters and Area Served
4.5 Key Players Companion Animal Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Companion Animal Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Zoetis
5.1.1 Zoetis Profile
5.1.2 Zoetis Main Business
5.1.3 Zoetis Companion Animal Drugs Products, Services and Solutions
5.1.4 Zoetis Companion Animal Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Zoetis Recent Developments
5.2 Bayer
5.2.1 Bayer Profile
5.2.2 Bayer Main Business
5.2.3 Bayer Companion Animal Drugs Products, Services and Solutions
5.2.4 Bayer Companion Animal Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Bayer Recent Developments
5.3 Boehringer Ingelheim
5.3.1 Boehringer Ingelheim Profile
5.3.2 Boehringer Ingelheim Main Business
5.3.3 Boehringer Ingelheim Companion Animal Drugs Products, Services and Solutions
5.3.4 Boehringer Ingelheim Companion Animal Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Eli Lilly Recent Developments
5.4 Eli Lilly
5.4.1 Eli Lilly Profile
5.4.2 Eli Lilly Main Business
5.4.3 Eli Lilly Companion Animal Drugs Products, Services and Solutions
5.4.4 Eli Lilly Companion Animal Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Eli Lilly Recent Developments
5.5 Merck
5.5.1 Merck Profile
5.5.2 Merck Main Business
5.5.3 Merck Companion Animal Drugs Products, Services and Solutions
5.5.4 Merck Companion Animal Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Merck Recent Developments
5.6 Vetoquinol
5.6.1 Vetoquinol Profile
5.6.2 Vetoquinol Main Business
5.6.3 Vetoquinol Companion Animal Drugs Products, Services and Solutions
5.6.4 Vetoquinol Companion Animal Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Vetoquinol Recent Developments
5.7 Virbac
5.7.1 Virbac Profile
5.7.2 Virbac Main Business
5.7.3 Virbac Companion Animal Drugs Products, Services and Solutions
5.7.4 Virbac Companion Animal Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Virbac Recent Developments
5.8 Dechra Pharmaceuticals
5.8.1 Dechra Pharmaceuticals Profile
5.8.2 Dechra Pharmaceuticals Main Business
5.8.3 Dechra Pharmaceuticals Companion Animal Drugs Products, Services and Solutions
5.8.4 Dechra Pharmaceuticals Companion Animal Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Dechra Pharmaceuticals Recent Developments
5.9 Ceva Sante Animale
5.9.1 Ceva Sante Animale Profile
5.9.2 Ceva Sante Animale Main Business
5.9.3 Ceva Sante Animale Companion Animal Drugs Products, Services and Solutions
5.9.4 Ceva Sante Animale Companion Animal Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 Ceva Sante Animale Recent Developments
5.10 Aratana Therapeutics
5.10.1 Aratana Therapeutics Profile
5.10.2 Aratana Therapeutics Main Business
5.10.3 Aratana Therapeutics Companion Animal Drugs Products, Services and Solutions
5.10.4 Aratana Therapeutics Companion Animal Drugs Revenue (US$ Million) & (2018-2023)
5.10.5 Aratana Therapeutics Recent Developments
6 North America
6.1 North America Companion Animal Drugs Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Companion Animal Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Companion Animal Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Companion Animal Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Companion Animal Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Companion Animal Drugs Market Dynamics
11.1 Companion Animal Drugs Industry Trends
11.2 Companion Animal Drugs Market Drivers
11.3 Companion Animal Drugs Market Challenges
11.4 Companion Animal Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
